Cargando…
Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
In this concept paper, the authors present a unique and novel protocol to treat autoimmune diseases that may have the potential to reverse autoimmunity. It uses a combination of B cell depletion therapy (BDT), specifically rituximab (RTX) and intravenous immunoglobulin (IVIg), based on a specificall...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058053/ https://www.ncbi.nlm.nih.gov/pubmed/30072982 http://dx.doi.org/10.3389/fimmu.2018.01189 |